COVIFENZ from Medicago - A Plant Based Vaccine from Canada for COVID-19

COVIFENZ from Medicago - A Plant Based Vaccine from Canada for COVID-19Show more

This Canadian plant based COVID-19 vaccine now approved in Canada has an overall 71% efficacy. Let's review.

If you like this content and want more, I am doing a special lifetime membership offer. Click here:
https://www.drbeen.com/yt-special/

Want to support this work?:
Buy me a coffee :-) https://www.buymeacoffee.com/DrMobeenSyed
Become my patron: https://www.patreon.com/mobeensyed?fan_landing=true
PayPal: https://paypal.me/mobeensyed?locale.x=en_US

My substack: https://mobeensyedmd.substack.com/

#drbeen #koolbeens #COVID

Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.

DrBeen: Continuing Medical Education Online | USMLE Prep | CME and CE marketplace | Nurse Practitioner and Physician Assistant Training Programs | Medical Student Training
https://www.drbeen.com/

URL list from Tuesday, Apr. 19 2022

Plant-based technology | Medicago
https://medicago.com/en/our-technologies/plant-based-technology/

Medicago and GSK announce the approval by Health Canada of COVIFENZ®, an Adjuvanted Plant-Based COVID-19 Vaccine | Medicago
https://medicago.com/en/press-release/covifenz/

Covifenz-PM-en.pdf
https://medicago.com/app/uploads/2022/02/Covifenz-PM-en.pdf

Covifenz-PMI-2.pdf
https://medicago.com/app/uploads/2022/02/Covifenz-PMI-2.pdf

GlaxoSmithKline, Medicago’s plant-based COVID vaccine, Covifenz, wins first approval | Fierce Pharma
https://www.fiercepharma.com/pharma/medicago-glaxosmithkline-s-plant-based-covid-19-vaccine-covifenz-wins-first-approval

Medicago and GSK announce positive Phase 3 efficacy and safety results for adjuvanted plant-based COVID-19 vaccine candidate | GSK
https://www.gsk.com/en-gb/media/press-releases/medicago-and-gsk-announce-positive-phase-3-efficacy-and-safety-results/#:~:text=The%20vaccine%20candidate%20demonstrated%20efficacy,PP)%20against%20the%20Gamma%20variant.

Plant-based technology | Medicago
https://medicago.com/en/our-technologies/plant-based-technology/#:~:text=The%20Proficia%C2%AE%20technology%20developed,that%20can%20successfully%20infect%20it.